AKT1 and Cowden disease: We hypothesized that IFX can simultaneously inhibit neutrophils to produce IL-8 and downregulate NF-κB and PI3K/Akt signaling pathways, which contribute to decreased migration of neutrophils, leading to the resolution of inflammation in intestinal mucosa in CD patients.